2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义

2017-03-01 国外消化科相关专家小组(统称) Aliment Pharmacol Ther. 2017 Mar;45(6):801-813.

越来越多的证据表明粘膜愈合与溃疡性结肠炎更好的预后相关,内镜检查确实可增加发育不良和结直肠癌风险。本文主要为参与临床试验的溃疡性结肠炎患者镜下应答和缓解提供相关定义。

中文标题:

2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义

英文标题:

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus

发布日期:

2017-03-01

简要介绍:

越来越多的证据表明粘膜愈合与溃疡性结肠炎更好的预后相关,内镜检查确实可增加发育不良和结直肠癌风险。本文主要为参与临床试验的溃疡性结肠炎患者镜下应答和缓解提供相关定义。


拓展指南:结肠炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义)] GetToolGuiderByIdResponse(projectId=1, id=f54801c001a3683c, title=2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义, enTitle=Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus, guiderFrom=Aliment Pharmacol Ther. 2017 Mar;45(6):801-813., authorId=null, author=, summary=越来越多的证据表明粘膜愈合与溃疡性结肠炎更好的预后相关,内镜检查确实可增加发育不良和结直肠癌风险。本文主要为参与临床试验的溃疡性结肠炎患者镜下应答和缓解提供相关定义。, cover=, journalId=null, articlesId=null, associationId=950, associationName=国外消化科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Mar 01 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=越来越多的证据表明粘膜愈合与溃疡性结肠炎更好的预后相关,内镜检查确实可增加发育不良和结直肠癌风险。本文主要为参与临床试验的溃疡性结肠炎患者镜下应答和缓解提供相关定义。 <div><br> </div> 拓展指南:<strong>与<font color=red>结肠炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=cb46f1c0013e96c1" title="2017 KASID指南:溃疡性结肠炎的管理(第2版)" target=_blank>2017 KASID指南:溃疡性结肠炎的管理(第2版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c0ffe1c00135a6fe" title="2017 APSA指南:巨结肠相关性小肠结肠炎的诊断和管理" target=_blank>2017 APSA指南:巨结肠相关性小肠结肠炎的诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b226d1c0013a93f9" title="2016 循证共识声明:急性重症溃疡性结肠炎" target=_blank>2016 循证共识声明:急性重症溃疡性结肠炎</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=885021c0013396e5" title="新生儿坏死性小肠结肠炎外科手术治疗专家共识" target=_blank>新生儿坏死性小肠结肠炎外科手术治疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5970e1c0013093fd" title="2016 新生儿坏死性小肠结肠炎小肠造瘘术后临床治疗专家共识" target=_blank>2016 新生儿坏死性小肠结肠炎小肠造瘘术后临床治疗专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%BB%93%E8%82%A0%E7%82%8E" target=_blank>有关结肠炎更多指南</a></ul>, tagList=[TagDto(tagId=101344, tagName=溃疡性结), TagDto(tagId=11496, tagName=肠炎), TagDto(tagId=313, tagName=临床), TagDto(tagId=3594, tagName=试验), TagDto(tagId=80883, tagName=镜下), TagDto(tagId=12139, tagName=应答), TagDto(tagId=8313, tagName=缓解), TagDto(tagId=17974, tagName=定义)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5139, appHits=204, showAppHits=0, pcHits=3708, showPcHits=2216, likes=138, shares=4, comments=3, approvalStatus=1, publishedTime=Fri May 19 09:35:00 CST 2017, publishedTimeString=2017-03-01, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri May 19 09:35:00 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 00:49:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义)])
2017 国际共识:溃疡性结肠炎临床试验中镜下应答和缓解的定义
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192783, encodeId=53f71192e830f, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 21:01:26 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812880, encodeId=bfa3812880fa, content=mark学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:29:11 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812877, encodeId=82c88128e701, content=缓解的定义?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:19:53 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2022-02-12 ms3000000637975859

    学习了,非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192783, encodeId=53f71192e830f, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 21:01:26 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812880, encodeId=bfa3812880fa, content=mark学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:29:11 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812877, encodeId=82c88128e701, content=缓解的定义?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:19:53 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 ms9000000107172093

    mark学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192783, encodeId=53f71192e830f, content=学习了,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 21:01:26 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812880, encodeId=bfa3812880fa, content=mark学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:29:11 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812877, encodeId=82c88128e701, content=缓解的定义?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201030/d4f9cda9838b4ced8e47258b7d2fa483/822ba90b8644401f8d14936df38a1720.jpg, createdBy=b0475413073, createdName=ms9000000107172093, createdTime=Tue Aug 25 00:19:53 CST 2020, time=2020-08-25, status=1, ipAttribution=)]
    2020-08-25 ms9000000107172093

    缓解的定义?

    0